Researchers at the Arizona State University Biodesign Institute can developed a new method of early disease detection.
Teenagers and young adults are at increased risk of suicide after being diagnosed with cancer, according to a new study.
Four cancers (prostate, breast, colorectal, lung) account for more than 50 percent of new cases.
Genetic sequencing technology is changing the way cancer is diagnosed and treated, but traditional specimen handling methods threaten to slow that progress.
A clinic-based technique of targeted biopsy using MRI and ultrasound may improve the diagnosis and management of prostate cancer.
Persons with inflammatory breast cancer who were using statins at time of diagnosis had better progression-free survival than did nonusers.
Sentinel lymph node surgery identified the presence of residual breast cancer in lymph nodes in nearly all patients in a recent study.
The American Society of Clinical Oncology has released a nearly 100-page report detailing the year's most significant developments in cancer.
Researchers looking at multiple different levels of changes in renal cell carcinoma are closer to determining how these tumors grow and survive.
Adding three-dimensional breast imaging to standard digital mammography increases diagnostic accuracy and reduces false-positive recall rates.
Inhibiting one protein eliminated metastasis of melanoma in lab studies, a finding that could lead to targeted therapies for a range of cancers.
Black women have the highest death rate from breast cancer of all racial and ethnic groups, and are 40% more likely to die of the disease than are white women, according to a new report from the CDC.
It may be reasonable to use methods other than colonoscopy to rescreen people who had negative results on their first screening colonoscopy.
Many persons who receive chemotherapy for incurable cancers may not understand that the treatment is unlikely to be curative.
Assessing how water moves through breast tissue may reduce false-positive findings among women undergoing dynamic contrast-enhanced MRI.
A simple three-question survey has been developed to help clinicians identify women who may be experiencing symptoms of ovarian cancer.
The quality of breast cancer surgery improved when percutaneous needle biopsy was performed preoperatively.
Earlier study findings that anthracycline- or trastuzumab-based treatment for breast cancer raises the risk for heart failure and cardiomyopathy can be extended to a more general population of women.
Among patients with colorectal cancer, 29% in a nationally representative sample were diagnosed after an emergency, such as an obstruction or perforation of the bowel.
Compared with prostatectomy, surveillance will likely reduce prostate cancer-specific survival only slightly and greatly enhance quality of life.
The somo-V Automated Breast Ultrasound System received FDA approval for use in combination with standard mammography in women with dense breast tissue.
Dividing bowel preparation solution into two doses resulted in better preparation quality, detection rates, and colonoscopy completion rates.
For female patients with an abnormal breast or cervical cancer screening result, patient navigation services help to decrease the time to diagnosis and helps vulnerable populations get the care they need in a timely manner.
Human papillomavirus (HPV) positivity alone is a poor biomarker for HPV-driven head and neck cancers, according to two recent studies.
An analysis of breath samples from patients with pulmonary nodules distinguished benign from malignant growths in a recent study.
One year after men undergo surgical removal of prostate cancer, they have significant anxiety, which appears to be linked to poor sexual satisfaction and depression.
Flow cytometry has been identified as better for checking for minimal residual disease than two other widely used methods to predict patient survival.
Overweight and obese women with hormone receptor (HR)-positive operable breast cancer have an increased risk of disease recurrence and death.
Persons with more than one glioblastoma tumor upon diagnosis experience significantly worse survival than do patients with a solitary lesion.
A lung cancer risk-prediction model effectively identified individuals who would benefit most from low-dose computed tomography (CT) screening.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|